Losing Muscle on Semaglutide or Tirzepatide? How to Protect Lean Mass During GLP-1 Weight Loss
GLP-1 medications such as semaglutide and tirzepatide can cause meaningful loss of lean muscle alongside fat — clinical trial body-composition data and research reviews have found that roughly a quarter to as much as 40% of total weight lost on these medications may come from lean tissue rather than fat. That share can often be reduced, though never eliminated entirely, with adequate protein intake, regular resistance training, and physician-guided monitoring of body composition throughout treatment.
Why GLP-1 weight loss isn't only fat loss
GLP-1 receptor agonists work by reducing appetite and slowing digestion, which leads to a sustained calorie deficit. Any time the body loses weight through a calorie deficit — whether from a GLP-1 medication, diet alone, or bariatric surgery — some of that weight comes from lean tissue, including muscle. This isn't unique to semaglutide or tirzepatide, but the scale of weight loss these medications produce means the absolute amount of muscle at stake is larger than with more modest weight-loss methods, which is why the topic has drawn so much attention from researchers, trainers, and patients in 2026.
How much muscle is actually at risk
Body-composition sub-studies from the major GLP-1 weight-loss trials, along with more recent research reviews, have reported that lean mass has made up roughly a quarter to around 40% of total weight lost, depending on the study, the medication, and how "lean mass" was measured. Lean mass includes more than skeletal muscle — it also includes water, organ tissue, and other non-fat components — so not all of that figure reflects muscle specifically. Individual results vary considerably based on age, starting body composition, protein intake, activity level, and how quickly weight is lost. These are research findings rather than a guarantee of what any one patient will experience, and no outcome can be promised in advance.
The three levers that appear to matter most
Protein intake
Across the available research and clinical guidance, adequate dietary protein is the most consistently cited factor in preserving lean mass during GLP-1-driven weight loss. Because appetite is often significantly reduced on these medications, hitting a protein target can take deliberate planning — prioritizing protein earlier in the day, using protein-forward meals, and in some cases a protein supplement, since appetite suppression can make a lower-volume, higher-density food strategy more realistic to sustain.
Resistance training
Regular resistance training is the other factor most often discussed alongside protein intake. Strength training provides a stimulus for the body to retain and build muscle even in a calorie deficit, and several clinical commentaries published in 2026 have recommended it as a standard companion to GLP-1 therapy rather than an optional add-on.
Monitoring, not guessing
Because lean mass isn't something you can accurately estimate by watching the number on a scale, tracking body composition — not just weight — over the course of treatment is how a care team can actually tell whether muscle is being preserved. This is part of why a physician-led program typically includes more than a prescription and a monthly check-in.
Where body composition tracking and peptide support fit into a Roots program
Roots' medical weight-loss programs are built around physician-guided titration rather than a flat, one-size-fits-all dose, and body composition is tracked over the course of treatment using Roots' AI 3D body composition scanner, so changes in lean mass — not just total weight — are visible and can inform adjustments to the plan. For patients who want to pair GLP-1 therapy with a structured strength and recovery approach, Roots' EmSculpt Neo sessions are sometimes used alongside a weight-loss program as a complement to resistance training, and some patients discuss growth hormone peptides such as those described in our piece on Sermorelin, Ipamorelin and CJC-1295 as part of a broader recovery and body-composition conversation with their provider. None of these are a substitute for protein intake and resistance training, and whether any of them make sense for you depends on your labs, goals, and health history.
What this means if you're on, or considering, a GLP-1 program
If you're currently on semaglutide or tirzepatide and concerned about muscle loss, the most useful next step is usually a conversation with your care team about your current protein intake, training routine, and whether a body composition scan would help clarify what's actually changing. If you're considering starting a GLP-1 program, building a protein and strength-training plan in from the beginning — rather than adding it later — is generally the more straightforward path. You can read more in our overview of semaglutide vs. tirzepatide and our medical weight-loss program page.
This article is educational and does not replace a consultation with Roots' medical team. Outcomes vary by patient, and any treatment plan — including GLP-1 therapy, body composition tracking, or peptide therapy — should be based on an individualized evaluation of your labs and health history.
Frequently asked questions
Does semaglutide or tirzepatide cause muscle loss?
Both medications can be associated with some loss of lean mass alongside fat loss, which is a recognized effect of GLP-1-driven weight loss generally rather than something specific to one brand. The amount varies by individual and is influenced by factors like protein intake, activity level, and the pace of weight loss.
How much of the weight lost on GLP-1 medications is muscle?
Research reviews and body-composition sub-studies have reported that lean tissue can make up roughly a quarter to around 40% of total weight lost, though this figure includes more than just skeletal muscle and varies by study and by patient. There's no single number that applies to everyone, and individual results are not guaranteed.
How can I prevent muscle loss while taking a GLP-1 medication?
The factors most consistently discussed in the research are adequate dietary protein, regular resistance training, and ongoing monitoring of body composition (not just scale weight) so a care team can adjust the plan if lean mass is declining faster than expected. These measures can help reduce lean-mass loss; they do not eliminate it entirely.
Does tirzepatide cause more or less muscle loss than semaglutide?
Because tirzepatide tends to produce greater total weight loss than semaglutide in clinical trials, some research has looked at whether that also means a larger absolute amount of lean mass lost, though findings are mixed and the proportion of lean-to-fat loss has been broadly similar between the two in several analyses. This is still an active area of research, and your prescribing clinician can speak to the latest evidence relative to your specific plan.
Can body composition scanning or strength training at Roots help preserve muscle during GLP-1 weight loss?
Tracking body composition over the course of treatment can help your care team see whether lean mass is being preserved and adjust your plan accordingly, and pairing GLP-1 therapy with a structured resistance-training routine is one of the most commonly recommended strategies in the current research. Whether additional tools like EmSculpt Neo sessions or peptide therapy make sense for you depends on an individualized evaluation with Roots' medical team.
Protect your muscle while you lose weight, with a plan built around your labs
If you're starting — or already on — a GLP-1 weight-loss program and want a plan that tracks lean mass, not just the scale, the next step is a consultation with Roots' medical team.